Cyborg | Designer-Babies | Futurism | Futurist | Immortality | Longevity | Nanotechnology | Post-Human | Singularity | Transhuman

Regenerative Arthritis | regenerative medicine How far out is the frontier in regenerative medicine that topic next Researchers pushing boundaries of regenerative medicine. Bryan Williams for…

By: Nathan Wei

See the article here:
Regenerative Arthritis | regenerative medicine – Video

Osiris – Company Presentation
Presented by: Lode Debrabandere, Ph.D., CEO Through over 20 years of research, experience and understanding, Osiris Therapeutics has led the way in mesenchymal stem cell (MSC) science and …

By: Alliance for Regenerative Medicine

Follow this link:
Osiris – Company Presentation – Video

TiGenix – Company Presentation
Presented by: Eduardo Bravo, CEO TiGenix was founded in 2000 to clinically develop and bring to market novel cell therapeutic products. In 2009, the Company became the first European company…

By: Alliance for Regenerative Medicine

See the article here:
TiGenix – Company Presentation – Video

Cytomedix – Company Presentation
Presented by: Martin Rosendale, CEO Cytomedix is an autologous regenerative therapies company commercializing innovative platelet technologies for wound care. The Company markets the …

By: Alliance for Regenerative Medicine

Read the original post:
Cytomedix – Company Presentation – Video

Organovo – Company Presentation
Presented by: Benjamin Shepherd, Ph.D., Pre-clinical Study Director Organovo designs functional human tissues. The Company's bioprinting technology enables the creation of 3D tissues that…

By: Alliance for Regenerative Medicine

See original here:
Organovo – Company Presentation – Video

RepliCel – Company Presentation
Presented by: David Hall, CEO RepliCel is a regenerative medicine company focused on autologous cell therapies that address diseases caused by a deficit of healthy cells required for healing…

By: Alliance for Regenerative Medicine

More here:
RepliCel – Company Presentation – Video

Regeneus – Company Presentation
Presented by: John Martin, Executive Chairman Regeneus is a Sydney-based regenerative medicine company founded in August 2007 that is focused on using the regenerative capacities of …

By: Alliance for Regenerative Medicine

See the original post here:
Regeneus – Company Presentation – Video

2014 10 23 11 02 3D Nanofiber Scaffolds for Regenerative Medicine
The use of nanofiber scaffolds has emerged as a promising approach for tissue engineering and regeneration owing to the favorable chemical and physical characteristics of nanofibers which mimic…

By: Akron Biotech

Read the original post:
2014 10 23 11 02 3D Nanofiber Scaffolds for Regenerative Medicine – Video

Contact Information

Available for logged-in reporters only

Newswise In a first-of-its-kind collaboration, the University of California, Los Angeles, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and University of California, Irvine Sue & Bill Gross Stem Cell Research Center received a five year $8M grant from the California Institute of Regenerative Medicine (CIRM), the states stem cell agency, to establish a CIRM Alpha Stem Cell Clinic center of excellence to conduct clinical trials for investigational stem cell therapies and provide critical resources and expertise in clinical research.

The $8M grant was one of three awarded today by CIRM as part of the CIRM Alpha Stem Cell Clinics (CASC) Network Initiative. The joint UCLA/UCI award under the direction of Dr. John Adams, a member of the UCLA Broad Stem Cell Research Center and professor in the department of orthopaedic surgery, will accelerate the implementation of clinical trials and delivery of stem cell therapies by providing world-class, state-of-the-art infrastructure to support clinical research.

CIRM grant reviewers lauded the UCLA/UCI Consortiums impressive and multidimensional team of experienced personnel that will expand access to patients, attracting national and international clinical trials and accelerating future trials in the pipeline.

The initial stem cell trials supported by the UCLA/UCI Alpha Stem Cell Clinic will be two UCLA projects using blood forming stem cells. The first trial will test a stem cell-based gene therapy for patients with bubble baby disease, also called severe combined immune deficiency (SCID), in which babies are born without an immune system. Under the direction of Dr. Donald Kohn, the clinical trial will use the babys own stem cells with an inserted gene modification to correct the defect and promote the creation of an immune system. The second clinical trial, under the direction of Dr. Antoni Ribas, will use patients own genetically modified blood-forming stem cells to engineer and promote an immune response to melanoma and sarcomas.

This CIRM Alpha Stem Cell Clinic grant is an important acknowledgement of our cutting-edge research and will help us to advance the design, testing and delivery of effective and safe stem cell-based therapies, said Dr. Owen Witte, professor and director of the Broad Stem Cell Research Center. The implementation of a standard of excellence in clinical research will improve healthcare and the lives of patients far beyond the longevity of individual trials.

Operating as part of the larger state-wide CIRM supported network, Alpha Stem Cell Clinics provide critical operational support to conduct clinical trials, with focused resources and expertise in stem cell-based clinical research including clinical operations support and patient care coordination personnel.

UCI has established a strong preclinical stem cell research program, and its vital to move ahead to the clinical testing phase, said Sidney Golub, director of UCIs Sue & Bill Gross Stem Cell Research Center. To advance treatments in this field, we all have to work together, and thats what the UCLA-UCI Alpha Stem Cell Clinic program represents.

About the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

Continue reading here:
UCLA and UCI Awarded $8M Grant to Launch Collaborative Stem Cell Clinic "Center of Excellence"

ECU-TV's Health Discoveries: Exploring Regenerative Medicine


Continue reading here:
ECU-TV’s Health Discoveries: Exploring Regenerative Medicine – Video

Stem Cells, Regenerative Medicine and Policy Impediments to the New Future
Oct. 21, 2014 Baker Institute nonresident scholar Deepak Srivastava explores the current and future potential of stem cells and regenerative medicine.

By: BakerInstitute

Follow this link:
Stem Cells, Regenerative Medicine and Policy Impediments to the New Future – Video

MIAMI (PRWEB) October 22, 2014

More than 900 physicians researchers and regenerative medicine experts from around the world attended the First International Symposium on Stem Cells and Regenerative Medicine, held in Buenos Aires, Argentina Oct. 2-4, 2014.

The event, hosted by Global Stem Cells Group in partnership with Julio Ferreira, M.D., President of the South American Academy Cosmetic Surgery, offered an opportunity for many of the worlds most respected authorities on stem cell and regenerative medicine to showcase advancements in research and therapies on a global level.

An interdisciplinary team of leading international stem cell experts provided a full day of high-level scientific lectures geared to medical professionals. Pioneers and luminaries in stem cell medicine who served as featured speakers at the event included:

Lord David Harrell, PhD., a scientific leader recognized nationally, internationally recognized expert in neuroscience and regenerative medicine and a member of the Global Stem Cells Group Advisory Board spoke on spoke on the cellular composition of bone marrow with a focus on stem and progenitor cell activities of bone marrow stem and progenitor cells.

Joseph Purita, M.D., Director of The Institute of Regenerative and Molecular Orthopedics in Boca Raton, Florida, member of the Global Stem Cells Group Advisory Board and a pioneer in the use of stem cells and platelet rich plasma for a variety of orthopedic conditions, spoke about the use of PRP and stem cell injections for treatment of musculoskeletal conditions. He detailed cutting-edge treatments he now offers to his clinic patients, including extensive use of platelet-rich plasma in conjunction with bone marrow stem cells (BMAC), adipose stem cells (SVF) and fat grafts.

Vasilis Paspaliaris, M.D., CEO of Adistem, Ltd., a member of the Global Stem Cells Group Advisory Board and a thought-leading and highly experienced clinical pharmacologist and medical scientist discussed the proven differences in efficacy between the mesenchyme stem cells (MSCs) of a young donor and those of an aging donor, primarily due to the younger donor cells ability to secrete more trophic factors.

According to Benito Novas, Global Stem Cells Group CEO, the world-class event was well received at a time when the field of regenerative medicine is on the verge of changing medical science forever.

We wanted the symposium to help clear up old misconceptions and change outdated attitudes by educating people on the wide range of illnesses and injuries stem cell therapies are already treating and curing, Novas says. We set out to establish a dialogue between researchers and practitioners in order to help move stem cell therapies from the lab to the physicians office and I believe we achieved our goals with this symposium.

Our objective is to open a dialogue among the worlds medical and scientific communities in order to advance stem cell technologies and translate them into point-of-care medical practices.

See the article here:
More than 900 Physicians Converge on Buenos Aires for Global Stem Cells Groups First International Symposium on Stem …

Regenerative Medicine The New Wave

By: Parker Foot Ankle

See more here:
Regenerative Medicine The New Wave – Video

3D Cell Bio-printing for Regenerative Medicine on the RAI Italian National TV – SuperQuark Program
Prof. Utkan Demirci, Dr. Rami El Assal, and Prof. Ali Khademhosseini at the Harvard-Massachusetts Institute of Technology (MIT) Health Science and Technology…

By: Rami EL Assal

Go here to read the rest:
3D Cell Bio-printing for Regenerative Medicine on the RAI Italian National TV – SuperQuark Program – Video

Akron Biotechnology, LLC , which provides novel technologies for cell therapy and regenerative medicine discovery, development, and commercialization, today announced its expansion and move to a new, larger facility.

Continued here:
Akron Biotech Expanding to New, State-of-the-Art Biotechnology Facility

OTTAWA , Oct.21, 2014 /CNW/ – The field of regenerative medicine harnessing the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs …

Visit link:
Media Advisory – Regenerative medicine experts come to Ottawa to share latest discoveries

Humacyte, a pioneer in regenerative medicine, today announced it will join U.S. Secretary of Commerce Penny Pritzker on a Development Mission to Japan and South Korea later this mo

Originally posted here:
Humacyte Selected to Join U.S. Secretary of Commerce On Trade Mission to Asia

Overview of Regenerative Medicine Partnering Merger Acquisition Market
The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals. The majority …

By: John Brown

Excerpt from:
Overview of Regenerative Medicine Partnering Merger & Acquisition Market – Video

Placenta Helps Heal Wounds
Using the placenta to help heal a patient's wounds. It's the latest wave in regenerative medicine. It's another option for doctors to treat patients with tough to heal open wounds, diabetic…

By: WTNH News8

Placenta Helps Heal Wounds – Video

Osiris Therapeutics, Inc. , the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that it has entered into an exclusive commercial and development partnership for its cartilage product, Cartiform, with Arthrex, Inc.

Read more:
Osiris and Arthrex announce an exclusive partnership for the commercialization and development of Cartiform

FireFox! Start Your Own Web Hosting Company
Web Hosting Advertise Here $10 a Month Affordable web-hosting
Pierre Teilhard De Chardin

Designer Children | Prometheism | Euvolution | Transhumanism

Sign up below for the Prometheism / Designer Children Discussion Forum

Subscribe to prometheism-pgroup

Powered by